Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darell D Bigner

Showing results (101-110 of 242) with videos related to

Pageof 25
Sort By:
Oncotarget|August 14, 2012
Mutant IDH1 is required for IDH1 mutated tumor cell growthGenglin Jin, Christopher J Pirozzi, Lee H Chen, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
Chemotherapy and novel therapeutic approaches in malignant gliomaAnnick Desjardins, Jeremy N Rich, Jennifer A Quinn, et al.
Nature Communications|January 29, 2020
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunityMubeen M Mosaheb, Elena Y Dobrikova, Michael C Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancerPeter M Grossi, Hidenobu Ochiai, Gary E Archer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2007
Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6Michael R Zalutsky, David A Reardon, Gamal Akabani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiformeChien-Tsun Kuan, Kenji Wakiya, Jeannette M Dowell, et al.
Nuclear Medicine and Biology|September 28, 2010
Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomasYukinari Kato, Ganesan Vaidyanathan, Mika Kato Kaneko, et al.
Cancer Immunology Research|February 27, 2014
Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibodyBryan D Choi, Patrick C Gedeon, James E Herndon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumorsAmy B Heimberger, Laura E Crotty, Gary E Archer, et al.
Plos One|February 8, 2011
A novel method for volumetric MRI response assessment of enhancing brain tumorsCharles W Kanaly, Dale Ding, Ankit I Mehta, et al.
Pageof 25

Showing results (101-110 of 242) with videos related to

Sort By:
Pageof 25
Oncotarget|August 14, 2012
Mutant IDH1 is required for IDH1 mutated tumor cell growthGenglin Jin, Christopher J Pirozzi, Lee H Chen, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
Chemotherapy and novel therapeutic approaches in malignant gliomaAnnick Desjardins, Jeremy N Rich, Jennifer A Quinn, et al.
Nature Communications|January 29, 2020
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunityMubeen M Mosaheb, Elena Y Dobrikova, Michael C Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancerPeter M Grossi, Hidenobu Ochiai, Gary E Archer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2007
Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6Michael R Zalutsky, David A Reardon, Gamal Akabani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiformeChien-Tsun Kuan, Kenji Wakiya, Jeannette M Dowell, et al.
Nuclear Medicine and Biology|September 28, 2010
Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomasYukinari Kato, Ganesan Vaidyanathan, Mika Kato Kaneko, et al.
Cancer Immunology Research|February 27, 2014
Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibodyBryan D Choi, Patrick C Gedeon, James E Herndon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumorsAmy B Heimberger, Laura E Crotty, Gary E Archer, et al.
Plos One|February 8, 2011
A novel method for volumetric MRI response assessment of enhancing brain tumorsCharles W Kanaly, Dale Ding, Ankit I Mehta, et al.
Pageof 25